Know your risk.
It may help save your life.
Genetic Technologies is a World Leader in Genetic Risk Assessment. Our brand geneType offers integrated risk testing for a range of serious conditions.
By knowing your risk, you and your healthcare professional can put together a personalised preventive health plan.
Take the first step towards personalised, preventative healthcare
Knowing your personalised risk enables you to develop a health plan with your healthcare professional to reduce your risk of serious disease. Select from the tests below to take the first step to managing your risk.
Breast Cancer
Find out if you are at increased risk of developing breast cancer
Bowel Cancer
Find out if you are at increased risk of developing bowel (colorectal) cancer
Multi-test
Find out if you are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes
Mental Health
Find out which antidepressant and dose could maximise your response and minimise side effects
Other Conditions
Find out if you are at increased risk of developing conditions such as glaucoma, melanoma or atrial fibrillation
COVID Severity
Find out if you are at risk of developing severe COVID symptoms
Quality matters
and geneType delivers.
Our expert scientific team has dedicated the last 20 years to translating research into validated clinical tests with actionable outcomes for patients.
Our extensive range of patents, peer-reviewed publications and validated tests reflects this commitment to making personalised, predictive healthcare a reality.
Coming Soon
GeneType Multi Test
A combination of geneType tests for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type 2 diabetes in a single test.
Know your risk of a serious disease to tailor a personalised prevention plan with your medical practitioner.
GeneType gives you the tools you need to provide personalised, preventative healthcare.
Genetype tests integrates clinical, familial and genetic risk factors to provide a more comprehensive risk profile.
For example, geneType for Breast Cancer supports identification of four times as many women who are at high risk for breast cancer compared with traditional prediction models.²
This information will then allow you and your healthcare professional to develop personalised, preventive health plans based on screening and risk factor management.
References
- Dite GS et al. Cancer Epidemiol Biomarkers Prev 2016;25:359–65.
- Genetic Technologies Ltd. Internal Unpublished Data.
Keep up-to-date with our latest advances
Sign up to our newsletter to stay informed about our latest advances and how these could support you.
Accredited For Compliance With NPAAC Standards And ISO 15189
